ICU Medical Q1 FY26 net income returns to profit at USD 30.1 million; revenue falls 12% to USD 530.2 million

ICU Medical, Inc.

ICU Medical, Inc.

ICUI

0.00
  • ICU Medical posted Q1 2026 revenue of USD 530.2 million, down 12% year over year.
  • Net income swung to USD 30.1 million, or USD 1.20 per diluted share, from a loss a year earlier.
  • Gross margin widened to 39% from 35%.
  • Consumables revenue rose to USD 278.3 million, while Vital Care revenue fell to USD 72.3 million following divestiture of IV Solutions business on May 1, 2025.
  • CEO Vivek Jain said first-quarter results were generally in line with expectations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ICU Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605071605PRIMZONEFULLFEED9715899) on May 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.